Angel Yeast Subsidiary to Invest RMB 370 Million in Synthetic Biology Pilot Base
Angel Yeast Co. , Ltd. (600298) announced on July 27 that its wholly-owned subsidiary, the Enzyme Preparation Company, plans to invest RMB 370 million to build a new synthetic biology pilot-scale validation base. The construction period of the project is 16 months.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Biotechnology, with intensity 50/100 and 75% confidence over a medium term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.